Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
29.13
+0.10 (0.34%)
At close: Oct 28, 2025, 4:00 PM EDT
29.13
0.00 (0.00%)
Pre-market: Oct 29, 2025, 4:18 AM EDT
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
$1,359,762
Profits / Employee
$511,147
Market Cap
17.95B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,682 | 478 | 21.69% |
| Dec 31, 2023 | 2,204 | 544 | 32.77% |
| Dec 31, 2022 | 1,660 | 448 | 36.96% |
| Dec 31, 2021 | 1,212 | 431 | 55.19% |
| Dec 31, 2020 | 781 | 233 | 42.52% |
| Dec 31, 2019 | 548 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GMAB News
- 5 days ago - Merus Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS - Business Wire
- 8 days ago - Why Is Genmab Stock Trading Lower On Monday? - Benzinga
- 10 days ago - Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Business Wire
- 14 days ago - Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025 - GlobeNewsWire
- 4 weeks ago - MERUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS - Business Wire
- 4 weeks ago - Genmab A/S (GMAB) M&A Call Transcript - Seeking Alpha
- 4 weeks ago - Genmab Makes $8 Billion Bet On Merus With Potential Cancer Breakthrough - Benzinga
- 4 weeks ago - This Dutch Drugmaker's Stock Is Jumping 38%. Here's Why It's Being Acquired. - Barrons